![Victoria Eatwell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Victoria Eatwell formerly worked at bluebird bio, Inc., as Vice President-Finance in 2021 and 2seventy Bio, Inc., as Chief Financial & Accounting Officer from 2024 to 2025.
Ms. Eatwell received her undergraduate degree from Wallace E Carroll School of Management.
Eerdere bekende functies van Victoria Eatwell
| Bedrijven | Functie | Einde |
|---|---|---|
| 2SEVENTY BIO, INC. | Financieel Directeur/CFO | 13-05-2025 |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01-11-2021 |
Opleiding van Victoria Eatwell
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
25
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Wallace E Carroll School of Management
 Wallace E Carroll School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
2seventy Bio, Inc.
 2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
Kies MarketScreener 
